Levodopa response motor complications--GABA receptors and preproenkephalin expression in human brain (Q34826230)

4 August 2017

1 reference

title

Levodopa response motor complications--GABA receptors and preproenkephalin expression in human brain (English)

1 reference

4 August 2017

1

1 reference

4 August 2017

2

Thérèse Di Paolo

1 reference

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

4 August 2017

number of pages

6

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

449-454

1 reference

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Motor Complications of Chronic Levodopa Therapy in Parkinsonʼs Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Dopamine-receptor stimulation: biobehavioral and biochemical consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Ageing and neurotoxins as causative factors in idiopathic Parkinson's disease--a critical analysis of the neurochemical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Striatal changes in preproenkephalin mRNA levels in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

The transcriptional regulation of the preproenkephalin gene

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: effects on basal ganglia GABA(A)/benzodiazepine receptor complex and GABA content

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

1 reference

7 January 2021

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Differential synaptic innervation of neurons in the internal and external segments of the globus pallidus by the GABA- and glutamate-containing terminals in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Two types of projection neurons in the internal pallidum of primates: single-axon tracing and three-dimensional reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Effects of riluzole on the electrophysiological activity of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Opposite motor effects of pallidal stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Pallidal stimulation for Parkinson's disease. Two targets?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Extrinsic connections of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

The distribution of the globus pallidus neurons with input from various cortical areas in the monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Microstimulation-induced inhibition of neuronal firing in human globus pallidus

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Does stimulation of the GPi control dyskinesia by activating inhibitory axons?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Regional and cellular localisation of GABA(A) receptor subunits in the human basal ganglia: An autoradiographic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

An update on GABAA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Multiple benzodiazepine receptors in the human basal ganglia: a detailed pharmacological and anatomical study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Zolpidem in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

Subhypnotic doses of zolpidem oppose dopaminergic-induced dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2802%2900029-9

7 January 2021

10.1016/S1353-8020(02)00029-9

Identifiers

DOI

1 reference

4 August 2017

1 reference